|
[1]GAO X, FAN JG, Study Group of Liver and Metabolism, Chinese Society of Endocrinology.Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders:consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology[J].J Diabetes, 2013, 5 (4) :406-415.
|
|
[2]ABD EL-KADER SM, EL-DEN ASHMAWY EM.Non-alcoholic fatty liver disease:The diagnosis and management[J].World J Hepatol, 2015, 7 (6) :846-58.
|
|
[3]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023.
|
|
[4]AHMED M.Non-alcoholic fatty liver disease in 2015[J].World J Hepatol, 2015, 7 (11) :1450-1459.
|
|
[5]MUSSO G, GAMBINO R, CASSADER M, et al.Meta-analysis:natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity[J].Ann Med, 2011, 43 (8) :617-649.
|
|
[6]BEDOSSA P, CARRAT F.Liver biopsy:the best, not the gold standard[J].J Hepatol, 2009, 50 (1) :1-3.
|
|
[7]RATZIU V, CHARLOTTE F, HEURTIER A, et al.Sampling variability of liver biopsy in nonalcoholic fatty liver disease[J].Gastroenterology, 2005, 128 (7) :1898-1906.
|
|
[8]BOHTE AE, van WERVEN JR, BIPAT S, et al.The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy:a meta-analysis[J].Eur Radiol, 2011, 21 (1) :87-97.
|
|
[9]PATEL UB, BROWN G, RUTTEN H, et al.Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer[J].Ann Surg Oncol, 2012, 19 (9) :2842-252.
|
|
[10]DOWMAN JK, TOMLINSON JW, NEWSOME PN.Systematic review:the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J].Aliment Pharmacol Ther, 2011, 33 (5) :525-540.
|
|
[11]MERKLE EM, NELSON RC.Dual gradient-echo in-phase and opposed-phase hepatic MR imaging:a useful tool for evaluating more than fatty infiltration or fatty sparing[J].Radiographics, 2006, 26 (5) :1409-1418.
|
|
[12]REEDER SB, HU HH, SIRLIN CB.Proton density fat-fraction:a standardized MR-based biomarker of tissue fat concentration[J].JMagn Reson Imaging, 2012, 36 (5) :1011-1014.
|
|
[13]REEDER SB, CRUITE I, HAMILTON G, et al.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy[J].J Magn Reson Imaging, 2011, 34 (4) :spcone.
|
|
[14]HU HH, KIM HW, NAYAK KS, et al.Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans[J].Obesity (Silver Spring) , 2010, 18 (4) :841-847.
|
|
[15]MEISAMY S, HINES CD, HAMILTON G, et al.Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat:blinded comparison with MR spectroscopy[J].Radiology, 2011, 258 (3) :767-775.
|
|
[16]REEDER SB.Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis[J].Hepatology, 2013, 58 (6) :1877-1880.
|
|
[17]SCHWIMMER JB, MIDDLETON MS, BEHLING C, et al.Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease[J].Hepatology, 2015, 61 (6) :887-895.
|
|
[18]BANNAS P, KRAMER H, HERNANDO D, et al.Quantitative magnetic resonance imaging of hepatic steatosis:Validation in ex vivo human livers[J].Hepatology, 2015, 62 (5) :1444-1455.
|
|
[19]DOYCHEVA I, CUI J, NGUYEN P, et al.Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE[J].Aliment Pharmacol Ther, 2016, 43 (1) :83-95.
|
|
[20]ARULANANDAN A, ANG B, BETTENCOURT R, et al.Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis[J].Clin Gastroenterol Hepatol, 2015, 13 (8) :1513-1520.e1.
|
|
[21]LOOMBA R, SIRLIN CB, ANG B, et al.Ezetimibe for the treatment of nonalcoholic steatohepatitis:assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) [J].Hepatology, 2015, 61 (4) :1239-1250.
|
|
[22]LE TA, CHEN J, CHANGCHIEN C, et al.Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis:a randomized controlled trial[J].Hepatology, 2012, 56 (3) :922-932.
|
|
[23]NOUREDDIN M, LAM J, PETERSON MR, et al.Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials[J].Hepatology, 2013, 58 (6) :1930-1940.
|
|
[24]WONG VW, VERGNIOL J, WONG GL, et al.Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease[J].Hepatology, 2010, 51 (2) :454-462.
|
|
[25]YIN M, TALWALKAR JA, GLASER KJ, et al.A preliminary assessment of hepatic fibrosis with magnetic resonance elastography[J].Clin Gastrenterol Hepatol, 2007, 5 (10) :1207-1213.e2.
|
|
[26]IIJIMA H, MORIYASU F, TSUCHIYA K, et al.Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis[J].Hepatol Res, 2007, 37 (9) :722-730.
|
|
[27]VERLOH N, UTPATEL K, HAIMERL M, et al.Liver fibrosis and Gd-EOB-DTPA-enhanced MRI:a histopathologic correlation[J].Sci Rep, 2015, 5:15408.
|
|
[28]SAITO K, LEDSAM J, SOURBRON S, et al.Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPAdynamic contrast-enhanced MRI:a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention[J].Eur Radiol, 2014, 24 (1) :112-119.
|
|
[29]CHO CS, CURRAN S, SCHWARTZ LH, et al.Preoperative radiographic assessment of hepatic steatosis with histologic correlation[J].J Am Coll Surg, 2008, 206 (3) :480-488.
|
|
[30]HAIMERL M, VERLOH N, ZEMAN F, et al.Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI[J].PLo S One, 2013, 8 (12) :e85658.
|
DownLoad: